Canterbury DHB
Many blood diseases and their treatments increase the risk of infection. The exact infection risk relates to a number of factors; most importantly, the severity and duration of neutropenia (e.g. AML and ALL induction treatments), and the degree of immunosuppression (ALL and intensive myeloma treatments, all allografts, GvHD). The measures to try and counteract this increased risk of infection will therefore vary according to the clinical situation. The following sections indicate the general principles and practice that are recommended.
Topic Code: 9468